table of contents 
In the present review the authors discussed the identification of selector, or …
|
1. Tosh D, Slack JMW. How cells change their phenotype. Nat Rev Mol Cell Biol. 2002; 3:187–94.
2. Beresford WA. Direct transdifferentiation: can cells change their phenotype without dividing? Cell Differ Dev. 1990; 29:81–93.
3. Slack JMW, Tosh D. Transdifferentiation and metaplasia - switching cell types. Curr Opin Genet Dev. 2001; 11: 581–6.
4. Taylor SM, Jones PA. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 1979; 17: 771–9.
5. Konieczny SF, Emerson CP Jr. 5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination, Cell 1984; 38: 791–800.
6. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987; 51: 987–1000.
7. Parker MH, Seale P, Rudnicki MA. Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat Rev Genet. 2003; 4: 497–507.
8. Weintraub H, Tapscott SJ, Davis RL, Thayer MJ, Adam MA, Lassar AB, Miller AD. Activation of musclespecific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci USA. 1989; 86: 5434–8.
9. Hu E, Tontonoz P, Spiegelman BM. Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR gamma and C/EBPα. Proc Natl Acad Sci USA. 1995; 92: 9856–60.
10. Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes Dev. 1995; 9: 168–81.
11. Wu Z, Xie Y, Bucher NL, Farmer SR. Conditional ectopic expression of C/EBPβ in NIH-3T3 cells induces PPARγ and stimulates adipogenesis. Genes Dev. 1995; 9: 2350–63.
12. Wu Z, Bucher NL, Farmer SR. Induction of peroxisome proliferator-activated receptor γ during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPβ, C/EBPδ, and glucocorticoids. Mol Cell Biol. 1996; 16: 4128–36.
13. Freytag SO, Paielli DL, Gilbert JD. Ectopic expression of the CCAAT/enhancer-binding protein α promotes the adipogenic program in a variety of mouse fibroblastic cells. Genes Dev. 1994; 8: 1654–63.
14. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor. Cell 1994; 79: 1147–56.
15. Ross SE, Hemati N, Longo KA, Bennett CN, Lucas PC, Erickson RL, MacDougald OA. Inhibition of adipogenesis by Wnt signaling. Science 2000; 289: 950–3.
16. Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev. 2000; 14: 1293–307.
17. Wells JM, Melton DA. Vertebrate endoderm development. Annu Rev Cell Dev Biol. 1999; 15: 393–410. 18. Slack JMW. Homoeotic transformations in man: implications for the mechanism of embryonic development and for the organization of epithelia. J Theor Biol. 1985; 114: 463–90.
19. Shen CN, Horb ME, Slack JMW, Tosh D. Transdifferentiation of pancreas to liver. Mech Dev. 2003;
120: 107–16.
20. Grompe M. Pancreatic-hepatic switches in vivo. Mech Dev. 2003; 120: 99–106.
21. Rao MS, Subbarao V, Reddy JK. Induction of hepatocytes in the pancreas of copper-depleted rats following copper repletion. Cell Differ. 1986; 18: 109–17.
22. Krakowski ML, Kritzik MR, Jones EM, Krahl T, Lee J, Arnush M, Gu D, Sarvetnick N. Pancreatic expression of keratinocyte growth factor leads to differentiation of islet hepatocytes and proliferation of duct cells. Am J Pathol. 1999; 154: 683–91.
23. Shen CN, Slack JMW, Tosh D. Molecular basis of transdifferentiation of pancreas to liver. Nat Cell Biol. 2000; 2: 879–87.
24. Tosh D, Shen CN, Slack JMW. Conversion of pancreatic cells to hepatocytes. Biochem Soc Trans. 2002; 30: 51–5.
25. Tosh D, Shen CN, Slack JMW. Differentiated properties of hepatocytes induced from pancreatic cells. Hepatology 2002; 36: 534–43.
26. Kurash JK, Shen CN, Tosh D. Induction and regulation of acute phase proteins in transdifferentiated hepatocytes. Exp Cell Res. 2004; 292: 342–58.
27. Descombes P, Schibler U. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 1991; 67: 569–79.
28. St-Onge L, Wehr R, Gruss P. Pancreas development and diabetes. Curr Opin Genet Dev. 1999; 9: 295–300.
29. Wilson ME, Scheel D, German MS. Gene expression cascades in pancreatic development. Mech Dev. 2003; 120: 65–80.
30. Kumar M, Melton D. Pancreas specification: a budding question. Curr Opin Genet Dev. 2003; 13: 401–7.
31. Deutsch G, Jung J, Zheng M, Lora J, Zaret KS. A bipotential precursor population for pancreas and liver within the embryonic endoderm. Development 2001; 128: 871–81.
32. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BL, Wright CV. PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 1996; 122: 983–95.
33. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 2002; 129: 2447–57.
34. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet. 1997; 15: 106–10.
35. Ferber S, Halkin A, Cohen H, Ber I, Einav Y, Goldberg I, Barshack I, Seijffers R, Kopolovic J, Kaiser N, Karasik A. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med. 2000; 6: 568–72.
36. Ber I, Shternhall K, Perl S, Ohanuna Z, Goldberg I, Barshack I, Benvenisti-Zarum L, Meivar-Levy I, Ferber S. Functional, persistent, and extended liver to pancreas transdifferentiation. J Biol Chem. 2003; 278: 31950–7.
37. Zalzman M, Gupta S, Giri RK, Berkovich I, Sappal BS, Karnieli O, Zern MA, Fleischer N, Efrat S. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc Natl Acad Sci USA 2003; 100: 7253–8.
38. Horb ME, Shen CN, Tosh D, Slack JM. Experimental conversion of liver to pancreas. Curr Biol. 2003; 13: 105–15.
39. Li WC, Horb ME, Tosh D, Slack JMW. In vitro transdifferentiation of hepatoma cells into functional pancreatic cells. Mech Dev. 2005; 122: 835–47.
40. Imai J, Katagiri H, Yamada T, Ishigaki Y, Ogihara T, Uno K, Hasegawa Y, Gao J, Ishihara H, Sasano H, Mizuguchi H, Asano T, Oka Y. Constitutively active PDX-1 induced efficient insulin production in adult murine liver. Biochem Biophys Res Commun. 2005; 326: 402–9.
41. Apelqvist A, Li H, Sommer L, Beatus P, Anderson DJ, Honjo T, Hrabe de Angelis M, Lendahl U, Edlund H. Notch signalling controls pancreatic cell differentiation. Nature 1999; 400: 877–81.
42. Gradwohl G, Dierich A, LeMeur M, Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000; 97: 1607–11.
43. Sommer L, Ma Q, Anderson DJ. Neurogenins, a novel family of atonal-related bHLH transcription factors, are putative mammalian neuronal determination genes that reveal progenitor cell heterogeneity in the developing CNS and PNS. Mol Cell Neurosci. 1996; 8: 221–41.
44. Jenny M, Uhl C, Roche C, Duluc I, Guillermin V, Guillemot F, Jensen J, Kedinger M, Gradwohl G. Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J. 2002; 21: 6338–47.
45. Heremans Y, Van De Casteele M, in't Veld P, Gradwohl G, Serup P, Madsen O, Pipeleers D, Heimberg H. Recapitulation of embryonic neuroendocrine differentiation in adult human pancreatic duct cells expressing neurogenin 3. J Cell Biol. 2002; 159: 303–12.
46. Suzuki A, Nakauchi H, Taniguchi H. Glucagon-like peptide 1 (1–37) converts intestinal epithelial cells into insulin-producing cells. Proc Natl Acad Sci USA 2003; 100: 5034–9.
47. Krapp A, Knofler M, Frutiger S, Hughes GJ, Hagenbuchle O, Wellauer PK. The p48 DNA-binding subunit of transcription factor PTF1 is a new exocrine pancreas- specific basic helix-loop-helix protein. EMBO J. 1996; 15: 4317–29.
48. Chiang MK, Melton DA. Single-cell transcript analysis of pancreas development. Dev Cell. 2003; 4: 383–93.
49. Lin JW, Biankin AV, Horb ME, Ghosh B, Prasad NB, Yee NS, Pack MA, Leach SD. Differential requirement for ptf1a in endocrine and exocrine lineages of developing zebrafish pancreas. Dev Biol. 2004; 270: 474–86.
50. Kawaguchi Y, Cooper B, Gannon M, Ray M, MacDonald RJ, Wright CV. The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet. 2002; 32: 128–34.
51. Ishibashi M, Ang SL, Shiota K, Nakanishi S, Kageyama R, Guillemot F. Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects. Genes Dev. 1995; 9: 3136–48.
52. Kageyama R, Ohtsuka T. The Notch-Hes pathway in mammalian neural development. Cell Res. 1999; 9: 179–88.
53. Jensen J, Pedersen EE, Galante P, Hald J, Heller RS, Ishibashi M, Kageyama R, Guillemot F, Serup P, Madsen OD. Control of endodermal endocrine development by Hes-1. Nat Genet. 2000; 24: 36–44.
54. Sumazaki R, Shiojiri N, Isoyama S, Masu M, Keino- Masu K, Osawa M, Nakauchi H, Kageyama R, Matsui A. Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. Nat Genet. 2004; 36: 83–7.
55. Burke ZD, Shen CN, Tosh D. Bile ducts as a source of pancreatic β cells. Bioessays 2004; 26: 932–7.
56. Cardoso WV. Lung morphogenesis revisited: old facts, current ideas. Dev Dyn. 2000; 219: 121–30.
57. Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, Cardaso WV. The molecular basis of lung morphogenesis. Mech Dev. 2000; 92: 55–81.
58. Ball DW. Achaete-scute homolog-1 and Notch in lung neuroendocrine development and cancer. Cancer Lett. 2004; 204: 159–69.
59. Ito T, Ukada N, Yazawa T, Okudela K, Hayashi H, Sudo T, Guillemot F, Kageyama R, Kitamura H. Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development 2000; 127: 3913–21.
60. Borges M, Linnoila RI, van de Velde HJ, Chen H, Nelkin BD, Mabry M, Baylin SB, Ball DW. An achaetescute homologue essential for neuroendocrine differentiation in the lung. Nature 1997; 386: 852–5.
61. Logan CY, Nusse R. The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 2004; 20: 781–810.
62. Shu W, Jiang YQ, Lu MM, Morrisey EE. Wnt7b regulates mesenchymal proliferation and vascular development in the lung. Development 2002; 129:4831–42.
63. Tebar M, Destree O, de Vree WJ, Ten Have-Opbroek AA. Expression of Tcf/Lef and sFrp and localization of β- catenin in the developing mouse lung. Mech Dev. 2001; 109: 437–40.
64. Okubo T, Hogan BLM. Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm. J Biol. 2004; 3:11.
65. Yang Q, Bermingham NA, Finegold MJ, Zoghby HY. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001; 294: 2155–8.
66. Wallis D, Hamblen M, Zhou Y, Venken KJ, Schumacher A, Grimes HL, Zoghbi HY, Orkin SH, Bellen HJ. The zinc finger transcription factor Gfi1, implicated in lymphomagenesis, is required for inner ear hair cell differentiation and survival. Development 2003; 130: 221–32.
67. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, Clevers H. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998; 19: 379–83.
68. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, Cameron A, Corley D, Falk G, Goldblum J, Hunter J, Jankowski J, Lundell L, Reid B, Shaheen NJ, Sonnenberg A, Wang K, Weinstein W. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop. Gastroenterology 2004; 127: 310–30.
69. Haggit RC, Tryzelaar J, Ellis FH, Colcher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol. 1978; 70: 1-5.
70. Bollschweiler E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001; 92: 549–55.
71. Tytgat GNJ, Bartelink H, Bernards R, Giaccone G, van Lanschot JJB, Offerhaus GJA, Peters GJ. Cancer of the esophagus and gastric cardia: recent advances. Diseases of the Esophagus 2004; 17: 10–26.
72. Murray L, Watson P, Johnston B, Sloan J, Mainie IM, Gavin A. Risk of adenocarcinoma in Barrett's oesophagus: population based study. Br Med J. 2003; 327: 534–5.
73. Montgomery E, Bronner MP, Goldblum JR, Greenson JK, Haber MM, Hart J, Lamps LW, Lauwers GY, Lazenby AJ, Lewin DN, Robert ME, Toleadano AY, Washington K. Reproducibility of the diagnosis of dysplasia in Barrett's esophagus: a reaffirmation. Hum Pathol. 2001; 32: 368–78.
74. Jenkins GJS, Doak SH, Parry JM, D'Souza FR, Griffiths AP, Baxter JN. Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma. Br J Surg. 2002; 89: 824–37.
75. German MS, Wang J, Fernald AA, Espinosa R. Localisation of the genes encoding two transcription factors, LMX1 and CDX3, regulating insulin gene expression to human chromosomes 1 and 13. Genomics 1994; 24:403–4.
76. Beck F, Erler T, Russell A, James R. Expression of Cdx-2 in the mouse embryo and placenta: possible role in the patterning of the extra-embryonic membranes. Dev Dyn. 1995; 204: 219–27.
77. James R, Kazenwadel J. Homeobox gene expression in the intestinal epithelium of adult mice. J Biol Chem. 1991; 266: 3246–51.
78. Silberg DG, Sullivan J, Kang E, Swain GP, Moffett J, Sund NJ, Sackett SD, Kaestner KH. Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice. Gastroenterology 2002; 122: 689–96.
79. Mutoh H, Hakamata Y, Sato K, Eda A, Yanaka I, Honda S, Osawa H, Kaneko Y, Sugano K. Conversion of gastric mucosa to intestinal metaplasia in Cdx2-expressing transgenic mice. Biochem Biophys Res Comm. 2002; 294: 470–9.
80. Beck F., The role of Cdx genes in the mammalian gut. Gut 2004; 53: 1394–6.
81. Chawengsaksophak K, James R, Hammond VE, Köntgen F., Beck F., Homeosis and intestinal tumours in Cdx2 mutant mice. Nature 1997; 386: 84–7.
82. Beck F, Chawengsaksophak K, Waring P, Playford RJ, Furness JB. Reprogramming of intestinal differentiation and intercalary regeneration in Cdx2 mutant mice. Proc Natl Acad Sci USA 1999; 96: 7318–23.
83. Faller G, Dimmler A, Rau T, Spaderna S, Hlubek F, Jung A, Kirchner T. Evidence for acid-induced loss of Cdx2 expression in duodenal gastric metaplasia. J Pathol. 2004; 203: 904–8.
84. Eda A, Osawa H, Yanaka I, Satoh K, Mutoh H, Kihira K, Sugano K. Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia. J Gastroenterol. 2002; 37: 94–100.
85. Eda A, Osawa H, Satoh K, Yanaka I, Kihira K, Ishino Y, Mutoh H, Sugano K. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol. 2003; 38: 14–22.
86. Phillips RW, Frierson HF, Moskaluk CA. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol. 2003; 27: 1442–7.
87. Moons LMG, Bax DA, Kuipers EJ, van Dekken H, Haringsma J, van Vliet AHM, Siersema PD, Kusters JG. The homeodomain protein CDX2 is an early marker of Barrett's oesophagus. J Clin Pathol. 2003; 57: 1063–8.
88. Mutoh H, Sakurai S, Satoh K, Osawa H, Hakamata Y, Takeuchi T, Sugano K. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: comparative study with Cdx2 transgenic mice. Gut 2004; 53: 1416–23.
89. Pomerantz J, Blau HM. Nuclear reprogramming: a key to stem cell function in regenerative medicine. Nat Cell Biol. 2004; 6: 810–6.
90. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest. 2003; 111: 843–50.
91. Ruhnke M, Ungefroren H, Nussler A, Martin F, Brulport M, Schormann W, Hengstler JG, Klapper W, Ulrichs K, Hutchinson JA, Soria B, Parwaresch RM, Heeckt P, Kremer B, Fandrich F. Differentiation of in vitro-modified human peripheral blood monocytes into hepatocyte-like and pancreatic islet-like cells. Gastroenterology 2005; 128: 1774–86.
92. Zhang Y-Q, Kritzik M, Sarvetnick N. Identification and expansion of pancreatic stem/progenitor cells. J Cell Mol Med. 2005; 9: 331–44.
93. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells with-in days without fusion. Nat Cell Biol. 2004; 6: 532-539, 2004
94. Ishikawa F, Drake CJ, Yang S, Fleming PA, Minamiguchi H, Visconti RP, Crosby CV, Argraves WS, Harada M, Key LL, Livingston AG, Wingard JR, Ogawa M. Transplanted human cord blood cells give rise to hepatocytes in engrafted mice. Hematopoietic stem cells 2002: Ann NY Acad Sci. 2003; 996: 174–85.
95. Newsome PN, Johannessen I, Boyle S, Dalakas E, McAulay KA, Samuel K, Rae F, Forrester L, Turner ML, Hayes PC, Harrison DJ, Bickmore WA, Plevris JN. Human cord blood-derived cells can differentiate into hepatocytes in the mouse liver with no evidence of cellular fusion. Gastroenterology 2003; 124: 1891–900.
96. LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 2002; 111: 589–601.
97. Corbel SY, Lee A, Yi L, Duenas J, Brazelton TR, Blau HM, Rossi FM. Contribution of hematopoietic stem cells to skeletal muscle. Nat Med. 2003; 9: 1528–32.
98. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, Fike JR, Lee HO, Pfeffer K, Lois C, Morrison SJ, Alvarez-Buylla A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003; 425: 968–73.
99. Weimann JM, Charlton CA, Brazelton TR, Hackman RC, Blau HM. Contribution of transplanted bone marrow cells to Purkinje neurons in human adult brains. Proc Natl Acad Sci USA 2003; 100: 2088–93.
100.Weimann JM, Johansson CB, Trejo A, Blau HM. Stable reprogrammed heterokaryons form spontaneously in Purkinje neurons after bone marrow transplant. Nat Cell Biol. 2003; 5: 959–66.
101. Lagasse E, Connors H, Al-Dhalimy M, Reitsma M, Dohse M, Osborne L, Wang X, Finegold M, Weissman IL, Grompe M. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med. 2000; 6: 1229–34.
102.Wang X, Willenbring H, Akkari Y, Torimaru Y, Foster M, Al-Dhalimy M, Lagasse E, Finegold M, Olson S., Grompe M. Cell fusion is the principal source of bonemarrow- derived hepatocytes. Nature 2003; 422: 897–901.
103.Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003; 422: 901–4.
104.Willenbring H, Bailey AS, Foster M, Akkari Y, Dorrell C, Olson S, Finegold M, Fleming WH, Grompe M. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med. 2004; 10: 744–8.
rating: 4.50 from 14 votes | updated on: 28 Oct 2006 | views: 1925 |
|
Answers to all your Biology Questions
